Emergent BioSolutions
EBS
#6682
Rank
HK$5.23 B
Marketcap
HK$98.17
Share price
0.72%
Change (1 day)
50.13%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2025 (TTM): HK$10.97

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is HK$10.96. In 2024 the company made an earnings per share (EPS) of -HK$28.21 an increase over its 2023 EPS that were of -HK$115.68.

EPS history for Emergent BioSolutions from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$10.97-138.86%
2024-HK$28.21-75.61%
2023-HK$115.68232.21%
2022-HK$34.82-203.46%
2021HK$33.66-25.09%
2020HK$44.93445.28%
2019HK$8.24-15.2%
2018HK$9.72-35.9%
2017HK$15.1669.57%
2016HK$8.94-27.67%
2015HK$12.3665.63%
2014HK$7.4611.63%
2013HK$6.6832.31%
2012HK$5.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Merck
MRK
HK$59.02 438.57%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$3.26-70.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$27.95 155.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-HK$26.27-339.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.37 21.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.90-55.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
-HK$25.18-329.79%๐Ÿ‡บ๐Ÿ‡ธ USA